OncoGenex Pharmaceuticals Inc. Reports Third Quarter 2009 Financial Results
11/6/2009 9:49:59 AM
More...
|
OncoGenex Pharmaceuticals Inc. to Release Third Quarter 2009 Financial Results
11/3/2009 9:31:36 AM
More...
|
OncoGenex Pharmaceuticals Inc. CEO Named Canada's Pacific Ernst & Young LLP's Entrepreneur Of The Year(R) in the Health Sciences Category
10/9/2009 10:37:34 AM
More...
|
FDA Grants Additional Fast Track Designation for OncoGenex Pharmaceuticals Inc.'s OGX-011 in Combination with First Line Chemotherapy
10/6/2009 8:04:09 AM
More...
|
OncoGenex Pharmaceuticals Inc. to Webcast Presentations at September Investor Conferences
9/3/2009 9:05:14 AM
More...
|
OncoGenex Pharmaceuticals Inc. Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
8/13/2009 7:10:16 AM
More...
|
OncoGenex Pharmaceuticals Inc. Announces Issuance of Key Patent for OGX-011
8/10/2009 8:03:31 AM
More...
|
OncoGenex Pharmaceuticals Inc. Reports Second Quarter 2009 Financial Results
8/7/2009 8:24:14 AM
More...
|
OncoGenex Pharmaceuticals Inc., Rising from Obscurity, Scopes Out Partners to Develop Prostate Cancer Drug
8/5/2009 7:53:19 AM
More...
|
OncoGenex Pharmaceuticals Inc. Completes $9.5 Million Registered Direct Offering
7/24/2009 8:32:37 AM
More...
|
|